RI
CSTL icon

Redwood Investments’s Castle Biosciences CSTL Stock Holding History

Redwood Investments’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-375,892
Closed -$16.9M – 126
2022
Q1 		$16.9M Buy
375,892
+202,099
+116% +$8.35M 1.6% 26
2021
Q4 		$7.45M Sell
173,793
-1,868
-1% -$97.6K 0.59% 63
2021
Q3 		$11.7M Sell
175,661
-10,830
-6% -$762K 0.98% 48
2021
Q2 		$13.7M Sell
186,491
-171
-0.1% -$11.3K 1.1% 42
2021
Q1 		$12.8M Sell
186,662
-126,430
-40% -$9.5M 1.12% 42
2020
Q4 		$21M Sell
313,092
-40,524
-11% -$2.2M 1.79% 19
2020
Q3 		$18.2M Buy
353,616
+287,087
+432% +$12.8M 1.53% 22
2020
Q2 		$2.51M Buy
+66,529
New +$2.27M 0.22% 88

Other funds holding CSTL

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.65B AUM 23.83% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Redwood Investments's CSTL Position: Q2 2022 in Review

Redwood Investments sold out of Castle Biosciences (CSTL) in Q2 2022, closing a stake of 375,892 shares — an estimated $16.9M sold.

Redwood Investments first reported a position in CSTL in Q2 2020 and held it in 8 quarters. The position peaked at $21M in Q4 2020. 146 funds tracked by Wall St. Rank hold CSTL as of Q2 2022.

  • Redwood Investments reported no remaining Castle Biosciences position as of Q2 2022 after selling out during the quarter.
  • Redwood Investments sold 375,892 Castle Biosciences shares in Q2 2022, an estimated $16.9M.
  • Redwood Investments first reported a position in Castle Biosciences in Q2 2020 and held it in 8 quarters.
  • Redwood Investments's Castle Biosciences position peaked at $21M in Q4 2020.
  • 146 funds tracked by Wall St. Rank held Castle Biosciences as of Q2 2022.

Based on Redwood Investments's 13F filing for Q2 2022, filed 15 Jul 2022.